IP Library Granted Patent US 7,723,544
Granted Patent B2
US 7,723,544 · App. 11/633,087 · Granted May 25, 2010

Process for recovery of iopromide, suitable for pharmaceutical purposes, from mother liquors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,544
App. No.
11/633,087
Granted
May 25, 2010
Kind
B2
Abstract

This invention describes a process for recovery of iopromide, suitable for pharmaceutical purposes, by heat treatment of the mother liquors or the secondary crystallizate in a reactor and subsequent crystallization.

Claims (8)

1. A process for recovery of iopromide, comprising recovering iopromide suitable for pharmaceutical purposes, by crystallization of dissolved secondary or subsequent crystallizate from iopromide mother liquor, after heat treatment of said dissolved secondary or subsequent crystallizate in a tubular flow reactor wherein the iopromide suitable for pharmaceutical purposes contains atropisomeric forms in an amount of 40-51% isomer 1 and 49-60% isomer 2.

2. A process according to claim 1 , in which iopromide that is contained in the mother liquor or the secondary or subsequent crystallizate has an isomeric ratio that is unsuitable for pharmaceutical purposes.

3. A process according to claim 1 , in which the heat treatment in a tubular-flow reactor is carried out at 100-300° C.

4. A process according to claims 1 , in which the crystallization is carried out from an alcohol.

5. A process according to claim 1 , whereby the iopromide suitable for pharmaceutical purposes is obtained by temperature treatment of atropisomers that are dissolved in a solvent.

6. A process according to claim 5 , whereby hydrodynamic dwell time of the atropisomers that are dissolved in a solvent in the tubular-flow reactor is 1 to 60 minutes.

7. A process according to claim 6 , in which water is used as a solvent.

8. A process for recovery of iopromide, comprising crystallizing iopromide from mother liquor, dissolving said iopromide in a solvent, heat treating said dissolved iopromide in a tubular flow reactor, and crystallizing iopromide suitable for pharmaceutical purposes wherein the iopromide suitable for pharmaceutical purposes contains atropisomeric forms in an amount of 40-51% isomer 1 and 49-60% isomer 2.

Assignments (4)
CHANGE OF NAME Recorded Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0668 →
CHANGE OF NAME Recorded Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →
CHANGE OF NAME Recorded Nov 14, 2007
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 020110/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2007
From: KAGERER, HARTMUT; DEMBECK, MEIKE; SEBA, HARTMUT; ORTMANN, INGO
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 019172/0571 →